- Home
- REXR vs CORT Comparison
REXR vs CORT Comparison
Compare REXR & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- CORT
- Stock Information
- Founded
- REXR 2013
- CORT 1998
- Country
- REXR United States
- CORT United States
- Employees
- REXR N/A
- CORT N/A
- Industry
- REXR Real Estate Investment Trusts
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- REXR Real Estate
- CORT Health Care
- Exchange
- REXR Nasdaq
- CORT Nasdaq
- Market Cap
- REXR 8.7B
- CORT 7.5B
- IPO Year
- REXR 2013
- CORT N/A
- Fundamental
- Price
- REXR $37.23
- CORT $72.98
- Analyst Decision
- REXR Hold
- CORT Strong Buy
- Analyst Count
- REXR 9
- CORT 4
- Target Price
- REXR $39.67
- CORT $142.00
- AVG Volume (30 Days)
- REXR 2.8M
- CORT 1.6M
- Earning Date
- REXR 07-16-2025
- CORT 07-28-2025
- Dividend Yield
- REXR 4.63%
- CORT N/A
- EPS Growth
- REXR 12.67
- CORT 8.36
- EPS
- REXR 1.23
- CORT 1.14
- Revenue
- REXR $974,598,000.00
- CORT $685,446,000.00
- Revenue This Year
- REXR $9.67
- CORT $35.83
- Revenue Next Year
- REXR $7.21
- CORT $35.24
- P/E Ratio
- REXR $30.21
- CORT $63.26
- Revenue Growth
- REXR 18.04
- CORT 30.93
- 52 Week Low
- REXR $29.68
- CORT $29.42
- 52 Week High
- REXR $52.61
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- REXR 58.62
- CORT 49.68
- Support Level
- REXR $34.92
- CORT $68.52
- Resistance Level
- REXR $36.99
- CORT $75.95
- Average True Range (ATR)
- REXR 0.86
- CORT 2.66
- MACD
- REXR -0.02
- CORT -0.13
- Stochastic Oscillator
- REXR 87.70
- CORT 42.13
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.